跳至主要内容
临床试验/ISRCTN55318937
ISRCTN55318937已完成3 期

A multicentre non-randomised interventional treatment trial looking at the treatment of children and young people with non-rhabdomyosarcoma soft tissue sarcomas

Central Manchester University Hospitals NHS Foundation Trust0 个研究点目标入组 40 人开始时间: 2010年5月19日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Eligibility criteria for the prospective non-randomised historically-controlled trial are the following:
  • 1. A pathologically proven diagnosis of synovial sarcoma and adult-type soft tissue sarcomas
  • 2. No evidence of metastatic lesions
  • 3. Age less than 21 years (20 years and 364 days) of age
  • 4. No previous treatment except for primary surgery
  • 5. For patients who require adjuvant chemotherapy according to protocol guidelines, no more than a 8 week-interval between the diagnostic surgical approach and the start of chemotherapy
  • 6. For patients who require adjuvant chemotherapy according to protocol guidelines, no pre-existing illness preventing treatment (in particular renal function must be equivalent to grade 0 - 1 nephrotoxicity, no prior history of cardiac disease and normal shortening fraction [greater than 28%] and ejection fraction [greater than 47%])
  • 7. No previous malignancy. Patients with post-irradiation soft part sarcomas could be registered and treated according to the protocol guidelines, but they will be analysed separately.
  • 8. Diagnostic material available for pathology review
  • 9. Available for long term follow up through the treatment centre
  • 10. Written informed consent for treatment available

排除标准

  • Does not meet inclusion criteria

研究者

相似试验